72 related articles for article (PubMed ID: 22790942)
1. Role of the myristoylation site in expressing exogenous functional proteins in coxsackieviral vector.
Lim BK; Yun SH; Ju ES; Gil CO; Kim DK; Jeon ES
Biosci Biotechnol Biochem; 2012; 76(6):1173-6. PubMed ID: 22790942
[TBL] [Abstract][Full Text] [Related]
2. Long-term cardiac gene expression using a coxsackieviral vector.
Lim BK; Shin JO; Lee SC; Kim DK; Choi DJ; Choe SC; Knowlton KU; Jeon ES
J Mol Cell Cardiol; 2005 May; 38(5):745-51. PubMed ID: 15850568
[TBL] [Abstract][Full Text] [Related]
3. Expression of an antigenic adenovirus epitope in a group B coxsackievirus.
Höfling K; Tracy S; Chapman N; Kim KS; Smith Leser J
J Virol; 2000 May; 74(10):4570-8. PubMed ID: 10775593
[TBL] [Abstract][Full Text] [Related]
4. A Gly1 to Ala substitution in poliovirus capsid protein VP0 blocks its myristoylation and prevents viral assembly.
Marc D; Girard M; van der Werf S
J Gen Virol; 1991 May; 72 ( Pt 5)():1151-7. PubMed ID: 1851815
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment.
Schmidtke M; Hammerschmidt E; Schüler S; Zell R; Birch-Hirschfeld E; Makarov VA; Riabova OB; Wutzler P
J Antimicrob Chemother; 2005 Oct; 56(4):648-56. PubMed ID: 16150864
[TBL] [Abstract][Full Text] [Related]
6. A glycine to alanine substitution in the paramyxovirus SV5 fusion peptide increases the initial rate of fusion.
Bagai S; Lamb RA
Virology; 1997 Nov; 238(2):283-90. PubMed ID: 9400601
[TBL] [Abstract][Full Text] [Related]
7. Formation of poliovirus-like particles by recombinant baculoviruses expressing the individual VP0, VP3, and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein.
Bräutigam S; Snezhkov E; Bishop DH
Virology; 1993 Feb; 192(2):512-24. PubMed ID: 8380663
[TBL] [Abstract][Full Text] [Related]
8. Tandem reporter assay for myristoylated proteins post-translationally (TRAMPP) identifies novel substrates for post-translational myristoylation: PKCε, a case study.
Martin DD; Ahpin CY; Heit RJ; Perinpanayagam MA; Yap MC; Veldhoen RA; Goping IS; Berthiaume LG
FASEB J; 2012 Jan; 26(1):13-28. PubMed ID: 21965604
[TBL] [Abstract][Full Text] [Related]
9. The amino-terminal nine amino acid sequence of poliovirus capsid VP4 protein is sufficient to confer N-myristoylation and targeting to detergent-insoluble membranes.
Martín-Belmonte F; López-Guerrero JA; Carrasco L; Alonso MA
Biochemistry; 2000 Feb; 39(5):1083-90. PubMed ID: 10653654
[TBL] [Abstract][Full Text] [Related]
10. Analysis of a potential myristoylation site in hepatitis A virus capsid protein VP4.
Tesar M; Jia XY; Summers DF; Ehrenfeld E
Virology; 1993 Jun; 194(2):616-26. PubMed ID: 8389076
[TBL] [Abstract][Full Text] [Related]
11. [Construction and functional study of a cell penetrating peptide-based expression vector for targeted delivery of proteins into the cell nuclei].
Li HY; Guo AH; Liu ZF; Liu Y; Liu JH; Deng P; Li ZJ; Liu YW; Jiang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1394-9, 1407. PubMed ID: 17062334
[TBL] [Abstract][Full Text] [Related]
12. Myristoylation is important at multiple stages in poliovirus assembly.
Moscufo N; Simons J; Chow M
J Virol; 1991 May; 65(5):2372-80. PubMed ID: 1850017
[TBL] [Abstract][Full Text] [Related]
13. Green fluorescent protein-tagged adeno-associated virus particles allow the study of cytosolic and nuclear trafficking.
Lux K; Goerlitz N; Schlemminger S; Perabo L; Goldnau D; Endell J; Leike K; Kofler DM; Finke S; Hallek M; Büning H
J Virol; 2005 Sep; 79(18):11776-87. PubMed ID: 16140755
[TBL] [Abstract][Full Text] [Related]
14. Mapping of a neutralizing antigenic site of Coxsackievirus B4 by construction of an antigen chimera.
Reimann BY; Zell R; Kandolf R
J Virol; 1991 Jul; 65(7):3475-80. PubMed ID: 1645779
[TBL] [Abstract][Full Text] [Related]
15. Systematic analysis of attenuated Coxsackievirus expressing a foreign gene as a viral vaccine vector.
Kim DS; Cho YJ; Kim BG; Lee SH; Nam JH
Vaccine; 2010 Feb; 28(5):1234-40. PubMed ID: 19941986
[TBL] [Abstract][Full Text] [Related]
16. Foreign gene transfer to cardiomyocyte using a replication-defective recombinant coxsackievirus B3 without cytotoxicity.
Lim BK; Yun SH; Gil CO; Ju ES; Choi JO; Kim DK; Jeon ES
Intervirology; 2012; 55(3):201-9. PubMed ID: 21821992
[TBL] [Abstract][Full Text] [Related]
17. A genetically engineered attenuated coxsackievirus B3 strain protects mice against lethal infection.
Dan M; Chantler JK
J Virol; 2005 Jul; 79(14):9285-95. PubMed ID: 15994822
[TBL] [Abstract][Full Text] [Related]
18. Sequence-independent acylation of the vaccinia virus A-type inclusion protein.
Yoder JD; Chen T; Hruby DE
Biochemistry; 2004 Jul; 43(26):8297-302. PubMed ID: 15222742
[TBL] [Abstract][Full Text] [Related]
19. Myristoylation of EV71 VP4 is Essential for Infectivity and Interaction with Membrane Structure.
Cao J; Qu M; Liu H; Wan X; Li F; Hou A; Zhou Y; Sun B; Cai L; Su W; Jiang C
Virol Sin; 2020 Oct; 35(5):599-613. PubMed ID: 32399947
[TBL] [Abstract][Full Text] [Related]
20. The role of myristoylation in the membrane association of the Lassa virus matrix protein Z.
Strecker T; Maisa A; Daffis S; Eichler R; Lenz O; Garten W
Virol J; 2006 Nov; 3():93. PubMed ID: 17083745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
